225 related articles for article (PubMed ID: 31874284)
21. Impact of idiopathic pulmonary fibrosis on recurrence after surgical treatment for stage I-III non-small cell lung cancer.
Song MJ; Kim DJ; Paik HC; Cho S; Kim K; Jheon S; Lee SH; Park JS
PLoS One; 2020; 15(6):e0235126. PubMed ID: 32598373
[TBL] [Abstract][Full Text] [Related]
22. Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.
Kim H; Pyo H; Noh JM; Lee W; Park B; Park HY; Yoo H
Radiat Oncol; 2019 Jan; 14(1):19. PubMed ID: 30691496
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic pulmonary fibrosis will increase the risk of lung cancer.
Li J; Yang M; Li P; Su Z; Gao P; Zhang J
Chin Med J (Engl); 2014; 127(17):3142-9. PubMed ID: 25189961
[TBL] [Abstract][Full Text] [Related]
24. Clinical features and prognosis of patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Lee SH; Park JS; Kim SY; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Park SW; Jeong SH; Park YB; Lee HL; Shin JW; Lee JH; Jegal Y; Lee HK; Kim YH; Song JW; Park MS
Int J Tuberc Lung Dis; 2019 Jun; 23(6):678-684. PubMed ID: 31315699
[TBL] [Abstract][Full Text] [Related]
25. Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.
Kanaji N; Tadokoro A; Kita N; Murota M; Ishii T; Takagi T; Watanabe N; Tojo Y; Harada S; Hasui Y; Kadowaki N; Bandoh S
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1855-65. PubMed ID: 27350261
[TBL] [Abstract][Full Text] [Related]
26. Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients.
Kim HC; Lee S; Song JW
Sci Rep; 2021 Apr; 11(1):8312. PubMed ID: 33859288
[TBL] [Abstract][Full Text] [Related]
27. Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study.
Sato S; Shimizu Y; Goto T; Kitahara A; Koike T; Ishikawa H; Watanabe T; Tsuchida M
BMC Pulm Med; 2018 Aug; 18(1):134. PubMed ID: 30097033
[TBL] [Abstract][Full Text] [Related]
28. Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses.
Guyard A; Danel C; Théou-Anton N; Debray MP; Gibault L; Mordant P; Castier Y; Crestani B; Zalcman G; Blons H; Cazes A
Respir Res; 2017 Jun; 18(1):120. PubMed ID: 28619094
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update.
Antoniou KM; Tomassetti S; Tsitoura E; Vancheri C
Curr Opin Pulm Med; 2015 Nov; 21(6):626-33. PubMed ID: 26390339
[TBL] [Abstract][Full Text] [Related]
30. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
[TBL] [Abstract][Full Text] [Related]
31. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
Respirology; 2017 Oct; 22(7):1379-1385. PubMed ID: 28543987
[TBL] [Abstract][Full Text] [Related]
32. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis.
Aubry MC; Myers JL; Douglas WW; Tazelaar HD; Washington Stephens TL; Hartman TE; Deschamps C; Pankratz VS
Mayo Clin Proc; 2002 Aug; 77(8):763-70. PubMed ID: 12173712
[TBL] [Abstract][Full Text] [Related]
33. The impact of lung cancer on survival of idiopathic pulmonary fibrosis.
Tomassetti S; Gurioli C; Ryu JH; Decker PA; Ravaglia C; Tantalocco P; Buccioli M; Piciucchi S; Sverzellati N; Dubini A; Gavelli G; Chilosi M; Poletti V
Chest; 2015 Jan; 147(1):157-164. PubMed ID: 25166895
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function.
Zhang X; Li W; Li C; Zhang J; Su Z
BMC Pulm Med; 2021 Apr; 21(1):122. PubMed ID: 33858421
[TBL] [Abstract][Full Text] [Related]
35. Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis.
Caliò A; Lever V; Rossi A; Gilioli E; Brunelli M; Dubini A; Tomassetti S; Piciucchi S; Nottegar A; Rossi G; Kambouchner M; Cancellieri A; Barbareschi M; Pelosi G; Doglioni C; Cavazza A; Carella R; Graziano P; Murer B; Poletti V; Chilosi M
Histopathology; 2017 Nov; 71(5):725-735. PubMed ID: 28556957
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of malignant diseases in idiopathic pulmonary fibrosis.
Lee HY; Cho J; Kwak N; Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Choi SM
Sci Rep; 2020 Oct; 10(1):18260. PubMed ID: 33106517
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
[TBL] [Abstract][Full Text] [Related]
38. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis.
Kawasaki H; Nagai K; Yoshida J; Nishimura M; Nishiwaki Y
J Surg Oncol; 2002 Sep; 81(1):33-7. PubMed ID: 12210025
[TBL] [Abstract][Full Text] [Related]
39. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece.
Tzouvelekis A; Karampitsakos T; Kontou M; Granitsas A; Malliou I; Anagnostopoulos A; Ntolios P; Tzilas V; Bouros E; Steiropoulos P; Chrysikos S; Dimakou K; Koulouris N; Bouros D
Pulm Pharmacol Ther; 2018 Apr; 49():61-66. PubMed ID: 29366978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
